nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—FLT4—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.0626	0.0859	CbGpPWpGaD
Vandetanib—PTK6—Focal Adhesion—RELN—otosclerosis	0.0478	0.0656	CbGpPWpGaD
Vandetanib—FYN—Reelin signaling pathway—RELN—otosclerosis	0.0337	0.0462	CbGpPWpGaD
Vandetanib—PDGFRB—Osteoblast Signaling—COL1A1—otosclerosis	0.0327	0.0448	CbGpPWpGaD
Vandetanib—ABL1—Lissencephaly gene (LIS1) in neuronal migration and development—RELN—otosclerosis	0.0314	0.043	CbGpPWpGaD
Vandetanib—PTK6—Focal Adhesion—COL1A1—otosclerosis	0.0257	0.0353	CbGpPWpGaD
Vandetanib—KDR—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.0201	0.0276	CbGpPWpGaD
Vandetanib—VEGFA—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.0181	0.0248	CbGpPWpGaD
Vandetanib—EGFR—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0156	0.0214	CbGpPWpGaD
Vandetanib—KDR—Integrins in angiogenesis—COL1A1—otosclerosis	0.0148	0.0203	CbGpPWpGaD
Vandetanib—TYRO3—connective tissue—otosclerosis	0.0147	0.0542	CbGeAlD
Vandetanib—LYN—connective tissue—otosclerosis	0.0146	0.0539	CbGeAlD
Vandetanib—RET—Dopaminergic Neurogenesis—TGFB1—otosclerosis	0.0143	0.0196	CbGpPWpGaD
Vandetanib—LCK—Inflammatory Response Pathway—COL1A1—otosclerosis	0.0142	0.0195	CbGpPWpGaD
Vandetanib—VEGFA—Integrins in angiogenesis—COL1A1—otosclerosis	0.0133	0.0183	CbGpPWpGaD
Vandetanib—SRC—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0133	0.0183	CbGpPWpGaD
Vandetanib—PDGFRB—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.0133	0.0183	CbGpPWpGaD
Vandetanib—VEGFA—Beta1 integrin cell surface interactions—COL1A1—otosclerosis	0.0128	0.0176	CbGpPWpGaD
Vandetanib—FLT3—connective tissue—otosclerosis	0.0125	0.0461	CbGeAlD
Vandetanib—BLK—Focal Adhesion—RELN—otosclerosis	0.0123	0.0169	CbGpPWpGaD
Vandetanib—FGR—Focal Adhesion—RELN—otosclerosis	0.0123	0.0168	CbGpPWpGaD
Vandetanib—MAP2K5—Focal Adhesion—RELN—otosclerosis	0.0117	0.0161	CbGpPWpGaD
Vandetanib—KDR—Focal Adhesion—RELN—otosclerosis	0.0114	0.0157	CbGpPWpGaD
Vandetanib—RIPK2—connective tissue—otosclerosis	0.0113	0.0416	CbGeAlD
Vandetanib—ERBB3—connective tissue—otosclerosis	0.0108	0.0398	CbGeAlD
Vandetanib—VEGFA—Focal Adhesion—RELN—otosclerosis	0.0103	0.0141	CbGpPWpGaD
Vandetanib—RET—connective tissue—otosclerosis	0.01	0.0369	CbGeAlD
Vandetanib—AXL—connective tissue—otosclerosis	0.00996	0.0368	CbGeAlD
Vandetanib—FYN—connective tissue—otosclerosis	0.00933	0.0344	CbGeAlD
Vandetanib—BLK—Glypican 1 network—TGFB1—otosclerosis	0.00922	0.0127	CbGpPWpGaD
Vandetanib—FGR—Glypican 1 network—TGFB1—otosclerosis	0.00919	0.0126	CbGpPWpGaD
Vandetanib—TEK—connective tissue—otosclerosis	0.00911	0.0336	CbGeAlD
Vandetanib—YES1—connective tissue—otosclerosis	0.00842	0.0311	CbGeAlD
Vandetanib—STK35—tendon—otosclerosis	0.0084	0.031	CbGeAlD
Vandetanib—ABL2—tendon—otosclerosis	0.00819	0.0302	CbGeAlD
Vandetanib—SRC—connective tissue—otosclerosis	0.0081	0.0299	CbGeAlD
Vandetanib—RIPK2—tendon—otosclerosis	0.00775	0.0286	CbGeAlD
Vandetanib—VEGFA—tendon—otosclerosis	0.00773	0.0285	CbGeAlD
Vandetanib—FMO1—tendon—otosclerosis	0.00768	0.0284	CbGeAlD
Vandetanib—VEGFA—Glypican 1 network—TGFB1—otosclerosis	0.00768	0.0105	CbGpPWpGaD
Vandetanib—IRAK4—tendon—otosclerosis	0.00756	0.0279	CbGeAlD
Vandetanib—PDGFRB—Focal Adhesion—RELN—otosclerosis	0.00755	0.0104	CbGpPWpGaD
Vandetanib—KDR—connective tissue—otosclerosis	0.00745	0.0275	CbGeAlD
Vandetanib—YES1—Glypican 1 network—TGFB1—otosclerosis	0.00742	0.0102	CbGpPWpGaD
Vandetanib—FYN—Focal Adhesion—RELN—otosclerosis	0.00727	0.00998	CbGpPWpGaD
Vandetanib—SRC—Integrins in angiogenesis—COL1A1—otosclerosis	0.00697	0.00956	CbGpPWpGaD
Vandetanib—FGR—tendon—otosclerosis	0.00688	0.0254	CbGeAlD
Vandetanib—RET—tendon—otosclerosis	0.00688	0.0254	CbGeAlD
Vandetanib—AXL—tendon—otosclerosis	0.00685	0.0253	CbGeAlD
Vandetanib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—otosclerosis	0.00663	0.0091	CbGpPWpGaD
Vandetanib—BLK—Focal Adhesion—COL1A1—otosclerosis	0.00662	0.00908	CbGpPWpGaD
Vandetanib—FGR—Focal Adhesion—COL1A1—otosclerosis	0.0066	0.00905	CbGpPWpGaD
Vandetanib—SLK—tendon—otosclerosis	0.00659	0.0243	CbGeAlD
Vandetanib—PDGFRB—connective tissue—otosclerosis	0.00645	0.0238	CbGeAlD
Vandetanib—FYN—tendon—otosclerosis	0.00641	0.0237	CbGeAlD
Vandetanib—MAP2K5—Focal Adhesion—COL1A1—otosclerosis	0.00629	0.00863	CbGpPWpGaD
Vandetanib—EGFR—Focal Adhesion—RELN—otosclerosis	0.00628	0.00862	CbGpPWpGaD
Vandetanib—MAP4K5—tendon—otosclerosis	0.00626	0.0231	CbGeAlD
Vandetanib—TEK—tendon—otosclerosis	0.00626	0.0231	CbGeAlD
Vandetanib—KDR—Focal Adhesion—COL1A1—otosclerosis	0.00613	0.00841	CbGpPWpGaD
Vandetanib—EPHB6—tendon—otosclerosis	0.00599	0.0221	CbGeAlD
Vandetanib—YES1—tendon—otosclerosis	0.00579	0.0214	CbGeAlD
Vandetanib—ABL1—connective tissue—otosclerosis	0.00575	0.0212	CbGeAlD
Vandetanib—STK10—tendon—otosclerosis	0.00573	0.0212	CbGeAlD
Vandetanib—LYN—Glypican 1 network—TGFB1—otosclerosis	0.00553	0.00759	CbGpPWpGaD
Vandetanib—VEGFA—Focal Adhesion—COL1A1—otosclerosis	0.00551	0.00756	CbGpPWpGaD
Vandetanib—FYN—Glypican 1 network—TGFB1—otosclerosis	0.00545	0.00747	CbGpPWpGaD
Vandetanib—SRC—Focal Adhesion—RELN—otosclerosis	0.00536	0.00735	CbGpPWpGaD
Vandetanib—MAP2K5—tendon—otosclerosis	0.00512	0.0189	CbGeAlD
Vandetanib—KDR—tendon—otosclerosis	0.00512	0.0189	CbGeAlD
Vandetanib—YES1—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00487	0.00668	CbGpPWpGaD
Vandetanib—KDR—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00483	0.00663	CbGpPWpGaD
Vandetanib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00482	0.00661	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—COL1A1—otosclerosis	0.00471	0.00647	CbGpPWpGaD
Vandetanib—VEGFA—Differentiation Pathway—TGFB1—otosclerosis	0.0047	0.00645	CbGpPWpGaD
Vandetanib—SRC—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00463	0.00635	CbGpPWpGaD
Vandetanib—LCK—Glypican 1 network—TGFB1—otosclerosis	0.00454	0.00622	CbGpPWpGaD
Vandetanib—PDGFRB—tendon—otosclerosis	0.00443	0.0164	CbGeAlD
Vandetanib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—otosclerosis	0.0042	0.00576	CbGpPWpGaD
Vandetanib—PDGFRB—Focal Adhesion—COL1A1—otosclerosis	0.00406	0.00556	CbGpPWpGaD
Vandetanib—SRC—Glypican 1 network—TGFB1—otosclerosis	0.00402	0.00551	CbGpPWpGaD
Vandetanib—ABL1—tendon—otosclerosis	0.00395	0.0146	CbGeAlD
Vandetanib—FYN—Focal Adhesion—COL1A1—otosclerosis	0.00391	0.00536	CbGpPWpGaD
Vandetanib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00385	0.00528	CbGpPWpGaD
Vandetanib—VEGFA—Endochondral Ossification—TGFB1—otosclerosis	0.00374	0.00513	CbGpPWpGaD
Vandetanib—FYN—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00358	0.00491	CbGpPWpGaD
Vandetanib—RIPK2—TCR Signaling Pathway—TGFB1—otosclerosis	0.00355	0.00487	CbGpPWpGaD
Vandetanib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00343	0.00471	CbGpPWpGaD
Vandetanib—EGFR—Focal Adhesion—COL1A1—otosclerosis	0.00338	0.00463	CbGpPWpGaD
Vandetanib—LYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00333	0.00457	CbGpPWpGaD
Vandetanib—FYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00328	0.0045	CbGpPWpGaD
Vandetanib—MKNK1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00321	0.0044	CbGpPWpGaD
Vandetanib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00321	0.0044	CbGpPWpGaD
Vandetanib—VEGFA—Allograft Rejection—TGFB1—otosclerosis	0.00316	0.00433	CbGpPWpGaD
Vandetanib—VEGFA—Platelet degranulation—TGFB1—otosclerosis	0.00313	0.00429	CbGpPWpGaD
Vandetanib—SRC—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00309	0.00425	CbGpPWpGaD
Vandetanib—ABCC1—tendon—otosclerosis	0.00301	0.0111	CbGeAlD
Vandetanib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00298	0.00409	CbGpPWpGaD
Vandetanib—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—otosclerosis	0.00298	0.00408	CbGpPWpGaD
Vandetanib—SRC—Focal Adhesion—COL1A1—otosclerosis	0.00288	0.00395	CbGpPWpGaD
Vandetanib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00274	0.00375	CbGpPWpGaD
Vandetanib—SRC—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.00264	0.00362	CbGpPWpGaD
Vandetanib—ABL1—Regulation of Telomerase—TGFB1—otosclerosis	0.00255	0.0035	CbGpPWpGaD
Vandetanib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00254	0.00349	CbGpPWpGaD
Vandetanib—SRC—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00242	0.00332	CbGpPWpGaD
Vandetanib—FYN—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—otosclerosis	0.00241	0.00331	CbGpPWpGaD
Vandetanib—EGFR—Regulation of Telomerase—TGFB1—otosclerosis	0.00218	0.00299	CbGpPWpGaD
Vandetanib—FYN—TCR Signaling Pathway—TGFB1—otosclerosis	0.00202	0.00277	CbGpPWpGaD
Vandetanib—MAP2K5—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00197	0.0027	CbGpPWpGaD
Vandetanib—ABL1—Cell Cycle—TGFB1—otosclerosis	0.00185	0.00253	CbGpPWpGaD
Vandetanib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.00175	0.0024	CbGpPWpGaD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00156	0.00214	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—TGFB1—otosclerosis	0.00148	0.00203	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—TGFB1—otosclerosis	0.00148	0.00203	CbGpPWpGaD
Vandetanib—EPHA8—Developmental Biology—TGFB1—otosclerosis	0.00143	0.00196	CbGpPWpGaD
Vandetanib—EGFR—Spinal Cord Injury—TGFB1—otosclerosis	0.0014	0.00192	CbGpPWpGaD
Vandetanib—VEGFA—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.00139	0.0019	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—TGFB1—otosclerosis	0.00134	0.00184	CbGpPWpGaD
Vandetanib—TEK—Hemostasis—TGFB1—otosclerosis	0.00133	0.00182	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—TGFB1—otosclerosis	0.00133	0.00182	CbGpPWpGaD
Vandetanib—SRC—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00131	0.0018	CbGpPWpGaD
Vandetanib—PDGFRB—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00127	0.00174	CbGpPWpGaD
Vandetanib—EPHA6—Developmental Biology—TGFB1—otosclerosis	0.00125	0.00171	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00112	0.00153	CbGpPWpGaD
Vandetanib—ALB—Platelet degranulation—TGFB1—otosclerosis	0.0011	0.00151	CbGpPWpGaD
Vandetanib—SRC—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00109	0.0015	CbGpPWpGaD
Vandetanib—EGFR—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00106	0.00145	CbGpPWpGaD
Vandetanib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—otosclerosis	0.00105	0.00144	CbGpPWpGaD
Vandetanib—LYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000999	0.00137	CbGpPWpGaD
Vandetanib—FYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000983	0.00135	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000955	0.00131	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—TGFB1—otosclerosis	0.000855	0.00117	CbGpPWpGaD
Vandetanib—LCK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000819	0.00112	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000814	0.00112	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—TGFB1—otosclerosis	0.000811	0.00111	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—TGFB1—otosclerosis	0.000729	0.000999	CbGpPWpGaD
Vandetanib—SRC—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000725	0.000994	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—TGFB1—otosclerosis	0.000715	0.00098	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—TGFB1—otosclerosis	0.000704	0.000965	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—TGFB1—otosclerosis	0.00069	0.000947	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—TGFB1—otosclerosis	0.000649	0.000891	CbGpPWpGaD
Vandetanib—MKNK1—Disease—TGFB1—otosclerosis	0.000643	0.000881	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—TGFB1—otosclerosis	0.000594	0.000814	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—TGFB1—otosclerosis	0.000543	0.000745	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TGFB1—otosclerosis	0.000525	0.00072	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TGFB1—otosclerosis	0.000522	0.000716	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TGFB1—otosclerosis	0.000517	0.000709	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—TGFB1—otosclerosis	0.000515	0.000706	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—TGFB1—otosclerosis	0.000512	0.000703	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—TGFB1—otosclerosis	0.000507	0.000695	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000489	0.000671	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TGFB1—otosclerosis	0.00045	0.000617	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TGFB1—otosclerosis	0.000446	0.000612	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—TGFB1—otosclerosis	0.000422	0.000579	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TGFB1—otosclerosis	0.000381	0.000522	CbGpPWpGaD
Vandetanib—ERBB3—Disease—TGFB1—otosclerosis	0.000381	0.000522	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—TGFB1—otosclerosis	0.000374	0.000512	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TGFB1—otosclerosis	0.000302	0.000415	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—otosclerosis	0.000277	0.000379	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—otosclerosis	0.00027	0.00037	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—otosclerosis	0.000267	0.000366	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—otosclerosis	0.000255	0.000349	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—otosclerosis	0.000252	0.000346	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—otosclerosis	0.000245	0.000337	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—otosclerosis	0.000242	0.000332	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—otosclerosis	0.000234	0.000321	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—otosclerosis	0.000225	0.000308	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—otosclerosis	0.000212	0.000291	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—otosclerosis	0.000204	0.00028	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—otosclerosis	0.000181	0.000248	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—otosclerosis	0.000178	0.000245	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—otosclerosis	0.000175	0.000239	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—otosclerosis	0.000172	0.000236	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—otosclerosis	0.000148	0.000204	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—otosclerosis	0.000143	0.000196	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—otosclerosis	0.000127	0.000174	CbGpPWpGaD
